Breast cancer survival rates have markedly improved. Consequently, survivorship issues
have received increased attention. One common sequel of treatment is chemotherapy …

Cancer-related cognitive impairment (CRCI) is a frequent side effect experienced by an
increasing number of cancer survivors with a significant impact on their quality of life …

As the population of cancer survivors has grown into the millions, there has been increasing
emphasis on understanding how the late effects of treatment affect survivors' ability to return …

Evidence suggests that some cancer survivors experience cognitive difficulties following
chemotherapy. However, perceived or subjective cognitive impairment is more frequently …

Purpose Evidence is mixed regarding long-term cognitive deficits in patients treated with
chemotherapy. Previous meta-analyses have not focused specifically on the …

Cancer-related cognitive impairment (CRCI) is commonly experienced by individuals with
non-central nervous system cancers throughout the disease and treatment trajectory. CRCI …

Purpose Cognitive symptoms are common in cancer patients, with up to 70% reporting
cognitive symptoms following chemotherapy. These symptoms can have a major impact on …

One consequence of modern cancer therapy is chemotherapy related cognitive dysfunction
or “chemobrain”, the subjective experience of cognitive deficits at any point during or …

Objective: Results from studies examining subjective cognitive dysfunctioning (SCD) in
breast cancer (BC) patients are unclear. Therefore, this review examined (i) the prevalence …

The purpose of this study was to evaluate the preliminary efficacy and satisfaction/
acceptability of training in memory or speed of processing versus wait-list control for …